Home
Conditions
Neoplasms, Squamous Cell

Clinical trial condition

Neoplasms, Squamous Cell

Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.

44 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Squamous Cell trial results

Completed

Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)

NCT01721525

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Neoplasms, +5 more
Locations: Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer

NCT01384708

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, +2 more
Locations: Mount Sinai Medical Center New York, United States

View Trial Details

Completed

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +36 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Study of Sorafenib/Cetuximab in Head and Neck Cancer

NCT00815295

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, +2 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

NCT01075828

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Neoplasms, +4 more
Locations: Chungnam National University Hospital Jung-gu Daejeon, South Korea

View Trial Details

Completed

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT00705016

Conditions: Disease Attributes, Neoplasm Metastasis, Neoplasms, +8 more
Locations: Research Site Salzburg, Austria

Research Site Vienna, Austria

Research Site Antwerp, Belgium

Research Site Brussels, Belgium

View all 37 locations

View Trial Details

Completed

Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

NCT01358097

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +15 more
Locations: Icahn School of Medicine at Mount Sinai, Otolaryngology - Head and Neck Surgery New York, United States

View Trial Details

Completed

Zalutumumab in Patients With Non-curable Head and Neck Cancer

NCT00382031

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Neoplasms, +5 more
Locations: University Hospital Antwerp Antwerp, Belgium

St-Luc University Hospital Brussels, Belgium

CHNDRF Charleroi, Belgium

"University Hospital Ghent, Belgium

View all 82 locations

View Trial Details

Completed

A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients

NCT01283906

Conditions: Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +11 more
Locations: Ironwood Cancer and Research Centers Mesa, Arizona, United States

21st Century Oncology TRC Headquarters Scottsdale, Arizona, United States

St. Joseph's Mercy Cancer Center- Hot Springs Radiation Oncology Hot Springs, Arkansas, United States

Enloe Medical Center- Cancer Center Chico, California, United States

View all 18 locations

View Trial Details

Completed

Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer

NCT00485485

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Neoplasms, +5 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neoplasms, Squamous Cell

Neoplasms, Squamous Cell trial results

Related conditions